Friday June 23rd 2017

Mass. Approves First 20 Medical Marijuana Dispensary Licenses

BOSTON (AP) — State public health officials awarded Friday the first 20 licenses to operate medical marijuana dispensaries, the first in Massachusetts under a voter-approved law. The Department of Public Health reviewed applications from 100 finalists seeking to operate the dispensaries. The law allows for up to 35 dispensaries around the state, and it was not immediately clear when additional licenses would be granted. Read: List of Approved Applications (.pdf) The law allows marijuana to be used for certain medical conditions, including cancer, multiple sclerosis and Parkinson’s disease. WBZ NewsRadio 1030′s Karen Twomey reports play pause Mass. Approves First 20 Medical Marijuana Dispensary Licenses Karen Twom…

Continue reading: 

Mass. Approves First 20 Medical Marijuana Dispensary Licenses

Leave a Comment

More from category

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation
MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]

MS Society Disappointed with Senate Healthcare Bill
MS Society Disappointed with Senate Healthcare Bill

/About-the-Society/News/HealthcareBill-6-22 [Read More]

Type I interferons could have role in natural improvement of RA during pregnancy
Type I interferons could have role in natural improvement of RA during pregnancy

An international US-Danish team of scientists, led by Damini Jawaheer, Ph.D. at the UCSF Benioff Children's Hospital [Read More]

Shared decision-making essential to optimal treatment and quality of life for patients with MS
Shared decision-making essential to optimal treatment and quality of life for patients with MS

One of the cornerstones of multiple sclerosis treatment is shared decision-making between patients and their doctors [Read More]

UC consortium formed to speed up development of new drugs
UC consortium formed to speed up development of new drugs

For 12 years, UCLA researcher Dennis Slamon pursued a groundbreaking approach to treating breast cancer: Attack the [Read More]